Sanders Morris Harris LLC Logic Bio Therapeutics, Inc. Transaction History

Sanders Morris Harris LLC

  • $585 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022
SELL
$2.2 - $4.53 $44,000 - $90,600
-20,000 Reduced 57.14%
15,000 $35,000
Q3 2021

Oct 13, 2021
BUY
$3.85 - $5.09 $77,000 - $101,800
20,000 Added 133.33%
35,000 $160,000
Q2 2021

Jul 13, 2021
BUY
$4.03 - $7.57 $60,450 - $113,550
15,000 New
15,000 $67,000

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Sanders Morris Harris LLC Portfolio

Follow Sanders Morris Harris LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanders Morris Harris LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email